Healthcare is transitioning from Volume-based care to Value Based Care. Volume-based care: the more patients the doctor sees the more money she makes; the more expensive procedures, the more money the doctor makes. Value-based care : How can you keep the patient healthy and out of expensive hospital room stays and emergency room visits. But there is a tension between this emerging Government goal of Value -based care and legal & regulatory barriers such as Fraud and Abuse and Antikickback ( with potential criminal exposure) that stand in the way of healthcare delivery becoming more efficient and productive. Add in Social Determinants of Healthcare that complicate this transition. This webinar offers strategy, marketing and legal suggestions for moving to Value-based care and navigating the regulatory landscape.
WHY SHOULD YOU ATTEND?
1. This transition has favorable government and regulatory leeway.
2. This webinar offers strategies, marketing and regulatory suggestions for making the transition.
3. This webinar includes analysis of Social Determinants of Healthcare (SDOH): where you live (Zip Code) / Quality of schools / Job Opportunities / Housing / Food Deserts / Transportation / For people who have been incarcerated, now what happens after they are released and seek to re-enter society
AREA COVERED
- Transitioning from Volume-based care to Value-based Care
- Integrating SDOH into the transition
- A strategic framework for moving to Value-based Care
- Managed Care, Medicare, Medicaid
- Regulatory sectors such as: The Office of Inspector General (OIG); The Dept. of Justice (DoJ); State Attorneys General; and very important > The Impact of Government Advisory Opinions
LEARNING OBJECTIVES
1. How to navigate the tension between moving to Value-based Care without transgressing legal and regulatory barriers
2. How to integrate Strategy, Marketing / Regulatory elements
3. What competing against the likes of vertical competitors like hi tech firms, health insurers and healthcare systems will look like
4. How to navigate “The Regulatory Sprint Toward Value-based Care
WHO WILL BENEFIT?
Anyone who works in Healthcare and deals with the non-clinical, business aspects of healthcare delivery: Doctors; Nurses; Hospital Administrators; Pharmacists; Allied Health Practitioners; Healthcare Adminstrators.
1. This transition has favorable government and regulatory leeway.
2. This webinar offers strategies, marketing and regulatory suggestions for making the transition.
3. This webinar includes analysis of Social Determinants of Healthcare (SDOH): where you live (Zip Code) / Quality of schools / Job Opportunities / Housing / Food Deserts / Transportation / For people who have been incarcerated, now what happens after they are released and seek to re-enter society
- Transitioning from Volume-based care to Value-based Care
- Integrating SDOH into the transition
- A strategic framework for moving to Value-based Care
- Managed Care, Medicare, Medicaid
- Regulatory sectors such as: The Office of Inspector General (OIG); The Dept. of Justice (DoJ); State Attorneys General; and very important > The Impact of Government Advisory Opinions
1. How to navigate the tension between moving to Value-based Care without transgressing legal and regulatory barriers
2. How to integrate Strategy, Marketing / Regulatory elements
3. What competing against the likes of vertical competitors like hi tech firms, health insurers and healthcare systems will look like
4. How to navigate “The Regulatory Sprint Toward Value-based Care
Anyone who works in Healthcare and deals with the non-clinical, business aspects of healthcare delivery: Doctors; Nurses; Hospital Administrators; Pharmacists; Allied Health Practitioners; Healthcare Adminstrators.
Speaker Profile
Dr. Bill Trombetta
Dr. Bill Trombetta is a Professor of Healthcare Strategy & Marketing at the Faculty of the Erivan K. Haub School of Business, St. Joseph’s University, Phila. PA. He received his Ph.D. from Ohio State University. He is also an attorney licensed in NY and NJ specializing in healthcare regulatory and antitrust law. Bill served as a Deputy Attorney General in The State of New Jersey, Dept. of Law & Public Safety, Div. of Criminal Justice, Antitrust Section. He has been invited to be a faculty member, adjunct, at Philadelphia College of Osteopathic Medicine (PCOM). He has been writing the annual …
Upcoming Webinars
Zero Acceptance Sampling to Reduce Inspection Costs
Project Management for Non-Project Managers - How to commun…
Why EBITDA Doesn't Spell Cash Flow and What Does?
FDA Compliance And Laboratory Computer System Validation
Workplace Investigations 101: How to Conduct your Investiga…
Do's and Don'ts of Documenting Employee Behaviour, Performa…
Fostering a Culture of Respect: Eliminating Gossip, Rumour…
Gossip-Free: Leadership Techniques to Quell Office Chatter
Human Error Trends as AI Enters GMP Operations: What QA Lea…
2026 EEOC & Employers: Investigating Claims of Harassment …
Stop Letting Toxic People Control Your Day
AI for Excel Professionals: Enhancing Productivity with Cha…
Building a High-Performance Team in 90 Days
Introduction to Microsoft Power BI Dashboards
Bootcamp for New Managers and Supervisors: Develop These Es…
Dealing with Difficult People: Managing Strong Personalitie…
The Perfect Storm Coming to Healthcare: Value Based Care Me…
Excel - Lists and Tables - A Beginner's Guide to Managing L…
Stop Letting That Difficult Person Ruin Your Day: Effective…
Reinvent Your HR Department with ChatGPT
Using Claude in Excel for Productivity, Automation & Data A…
DOL Reverses Course on Independent Contractor Rule for 2026…
FDA Technology Modernization Action Plan (TMAP) and Impact …
GROUPBY and PIVOTBY functions. Pivot table killers?
Discover how Emotional Intelligence turns AI from a technic…
Sunshine Act Reporting - Clarification for Clinical Research
FDA Recommendations for Artificial Intelligence/Machine Lea…
Cleanroom, Microbiology and Sterility Assurance Practices f…
Faster, Better Talent Acquisition: Leveraging AI & ChatGPT …
Data Integrity and Privacy: Compliance with 21 CFR Part 11,…
FDA Audit Best Practices - Do's and Don'ts
Medical Device Hazard analysis following ISO 14971
Interactive dashboards & analytics in Excel